血管前置及其相关危险因素:系统综述与荟萃分析
该系统综述与荟萃分析纳入21项研究、428例血管前置妊娠和1,027,918次分娩,计算血管前置发生率为每1000次分娩0.46例,并汇总低置胎盘、帆状脐带插入、双叶/副叶胎盘、体外受精和多胎妊娠等已知危险因素的合并患病率。作者建议重新评估血管前置筛查策略的成本效益。
要点
- 血管前置发生率为每1000次分娩0.46例。
- 低置胎盘患病率61.5%(95%CI 53.0%-70.0%)。
- 帆状脐带插入患病率52.2%(95%CI 39.6%-64.7%)。
核心结论
- 血管前置影响每1000次妊娠中的0.46例。
- 鉴于受累妊娠中产前可检测危险因素的高患病率,应重新评估血管前置筛查策略的成本效益。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、Cochrane Library、PubMed(非MEDLINE及in process)和clinicaltrials.gov,从建库至2018年3月。
- 纳入报告5例及以上血管前置妊娠的原始研究,限人类数据和英文发表。
- 共纳入21项研究,报告428例血管前置妊娠和1,027,918次分娩。
- 两位评价者独立筛选文献、提取数据并使用美国国家心肺血液研究所病例系列研究质量评估工具评价报告质量。
主要发现
- 血管前置发生率为每1000次分娩0.46例(428/1,027,918)。
- 低置胎盘患病率61.5%(95%CI 53.0%-70.0%)。
- 帆状脐带插入患病率52.2%(95%CI 39.6%-64.7%)。
- 双叶或副叶胎盘患病率33.3%(95%CI 20.9%-45.7%)。
- 体外受精使用率26.4%(95%CI 16.0%-36.8%),多胎妊娠率8.92%(95%CI 5.33%-12.5%)。
临床怎么用
- 临床应关注血管前置的产前可检测危险因素,包括低置胎盘、帆状脐带插入、双叶/副叶胎盘、体外受精和多胎妊娠。
- 可考虑重新评估单独筛查、基于危险因素的筛查或普遍筛查联合经阴道超声宫颈长度筛查的成本效益。
局限性
- 检索截至2018年3月,未纳入此后发表的研究。
- 仅纳入英文发表的研究。
- 纳入研究为病例系列等原始研究,使用美国国家心肺血液研究所病例系列研究质量评估工具评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review published literature and calculate the prevalence of vasa previa and its known risk factors. MATERIALS AND METHODS: MEDLINE, Embase, the Cochrane Library, PubMed (non-MEDLINE and in process), and www.clinicaltrials.gov were searched from inception to March 2018 using indexing terms "vasa previa," "placenta previa," "low lying placenta," "succenturiate lobe," "bilobate placenta," "bilobed placenta," and "velamentous insertion." All original research studies reporting on 5 or more pregnancies with vasa previa were included. The search was limited to studies on human data and those published in the English language. Two reviewers independently screened titles and abstracts, completed data extraction, and assessed reporting quality using the Study Quality Assessment Tool for Case Series Studies of the National Heart, Lung, and Blood Institute. Disagreements were discussed and resolved at each step of the process. RESULTS: We included 21 studies that reported 428 pregnancies with vasa previa of 1,027,918 deliveries (0.46 cases of vasa previa per 1000 deliveries). These studies fared well on risk of bias assessment using the Study Quality Assessment Tool for Case Series Studies of the National Heart, Lung, and Blood Institute. The prevalence and 95% confidence intervals of known risk factors for vasa previa included a low-lying placenta (61.5%, 53.0%-70.0%), velamentous cord insertion (52.2%, 39.6%-64.7%), bilobed or succenturiate lobed placenta (33.3%, 20.9%-45.7%), use of in vitro fertilization (26.4%, 16.0%-36.8%), and multiple gestation (8.92%, 5.33%-12.5%). CONCLUSION: Vasa previa affects 0.46 cases per 1000 pregnancies. Given the high prevalence of prenatally detectable risk factors in affected pregnancies, the cost-effectiveness of screening strategies for vasa previa either in isolation, using a risk factor-based approach, or universally, in tandem with cervical-length screening using transvaginal ultrasound, should be revisited.
引用
- Pavalagantharajah S, Villani LA, D'Souza R, et al. Vasa previa and associated risk factors: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020. PMID: 33345868. doi:10.1016/j.ajogmf.2020.100117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。